The Cardioprotective Effect of Fosinopril on Myocardial Infarction (MI) is Associated With the AMPK/mTOR Pathway
Journal of Biochemical and Molecular Toxicology · 2026-12 · 40 (12)
DOI: 10.1002/jbt.71210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 22.11.2026. Verfasst von Pei‐hua Ren und 4 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
To investigate the impact of fosinopril on cardiac function and its regulatory role in autophagy and the AMPK/mTOR pathway in a rat model of myocardial infarction (MI). MI was induced in rats by ligation of the left anterior descending coronary artery. MI modeling was verified by serum cardiac enzyme assays. Cardiac functions and histological change were determined by echocardiography, hematoxylin‐eosin (HE) staining, and Masson's trichrome staining. Autophagy‐associated factors were evaluated using western blotting and RT‐qPCR. Apoptosis was analyzed by TUNEL assay, while alterations in the phosphorylation of the AMPK/mTOR pathway were determined by western blotting. Serum CK‐MB and cTn‐I levels were significantly elevated in MI rats, confirming myocardial injury. MI rats showed disordered myocardial architecture with inflammatory infiltration, compromised cardiac function (increased left ventricular end‐systolic diameter and left ventricular end‐diastolic diameter, decreased left ventricular fractional shortening and left ventricular ejection fraction) and myocardial fibrosis. Molecularly, RT‐qPCR showed no significant changes in LC3 and p62/SQSTM1 mRNA levels, but Beclin‐1 mRNA expression was elevated in MI rats and partially reversed by fosinopril. Western blotting revealed an increased LC3b‐II/LC3b‐I ratio and Beclin‐1 protein expression, as well as decreased p62/SQSTM1 protein expression in MI rats. The TUNEL assay showed elevated apoptotic rates. MI also altered the phosphorylation status of the AMPK/mTOR pathway. Fosinopril reversed these changes except for the mRNA levels of LC3 and p62/SQSTM1. Fosinopril ameliorates MI‐induced cardiac dysfunction and myocardial fibrosis. Its cardioprotective effects may be attributed to the regulation of autophagy (via Beclin‐1 and other autophagy‐related proteins) and apoptosis through normalization of the dysregulated AMPK/mTOR pathway.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ren, P., Zhang, Z., Tan, W., Zhu, H., & Li, Z. (2026). The Cardioprotective Effect of Fosinopril on Myocardial Infarction (MI) is Associated With the AMPK/mTOR Pathway. Journal of Biochemical and Molecular Toxicology, 40(12). https://doi.org/10.1002/jbt.71210
Vancouver
Ren P, Zhang Z, Tan W, Zhu H, Li Z. The Cardioprotective Effect of Fosinopril on Myocardial Infarction (MI) is Associated With the AMPK/mTOR Pathway. Journal of Biochemical and Molecular Toxicology. 2026;40(12). doi:10.1002/jbt.71210
BibTeX
@article{Ren2026,
author = {Ren, Pei‐hua and Zhang, Zhi‐min and Tan, Wei‐lu and Zhu, Han‐ping and Li, Zhen‐qiu},
title = {The Cardioprotective Effect of Fosinopril on Myocardial Infarction (MI) is Associated With the AMPK/mTOR Pathway},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
volume = {40},
number = {12},
doi = {10.1002/jbt.71210}
}
EUVIMED